Lv1
60 积分 2024-03-07 加入
Early respon se to guselkumab and biologic-naïve status predict sustained efficacy with extended dosing intervals in mild-to-moderate plaque psoriasis: A real-world retrospective study
5天前
已完结
A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasis
1个月前
已完结
Risk of fungal infection in patients with psoriasis receiving biologics: A retrospective single-center cohort study
1个月前
已完结
Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study
2个月前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
4个月前
已完结
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial
5个月前
已关闭
Proton density fat fraction for diagnosis of metabolic dysfunction–associated steatotic liver disease
7个月前
已完结
PCSK9 inhibitors and the risk of vitiligo: a Mendelian randomization study
7个月前
已完结
Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia: The Randomized, Phase 3 REMAIN-2 Trial
11个月前
已完结
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial
11个月前
已完结
皖公网安备34019202002308
